We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Deep Learning Model Helps Drug Developers Target SARS-CoV-2's Main Protease

News   Oct 29, 2020 | Original story from Michigan State University

 
Deep Learning Model Helps Drug Developers Target SARS-CoV-2's Main Protease

Credit: Daniel Roberts/ Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Mouse Study Shows How Microbiota Changes Can Affect Sleep

News

Researchers have found that normal sleep in mice depends on bacteria that help make neurotransmitters such as serotonin in the gut.

READ MORE

Risk of Pre-Eclampsia Related to Blood Pressure and BMI

News

New research has revealed that the genetic risk of pre-eclampsia is related to blood pressure and body mass index.

READ MORE

Addressing the Plastic Polution Crisis With Chemistry and AI

News

Researchers are developing a novel set of tools that aim to reduce plastic waste and production.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Informatics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE